Startups

Syremis Therapeutics

Syremis Therapeutics is a clinical-stage biopharmaceutical company developing neuropsychiatric medicines, including M1/M4 muscarinic agonists and next-generation NMDA antagonists.

Founded 2025

Team

Elena KaganCo-founder and Chief Development Officer

Elisabeth KoganCo-founder and CEO

Menashe LevyCo-founder and CTO

Investments

$165M2025-12-18	Dexcel Pharma, Third Rock Ventures, Bain Capital Life Sciences, GV, QVT Family Office, Pictet
$165MUnknown date	Bain Capital, Third Rock Ventures